Qing Chen

Qing Chen is an accomplished professional in biophysics and biochemistry with extensive experience in leading research teams and developing biophysical assays. Currently serving as the Director of Biophysics and Biochemistry at Odyssey Therapeutics since March 2022, Qing previously held positions at Merck as Associate Principal Scientist and Group Leader, and at X-Chem, Inc. as a Senior Scientist. Significant contributions include the establishment of biophysical service platforms and advanced project developments at Reaction Biology Corporation and other organizations. Qing holds a Ph.D. in Protein X-ray Crystallography from EMBL/Heidelberg University and a Master's in Biochemistry and Molecular Biology from Shanghai Institutes of Materia Medica. Additionally, educational background includes a Bachelor's degree in Biology from East China Normal University.